TABLE 2.
Upstream, downstream, and interacting genes of MYCN.
| Category | Gene/target | Class | Mechanism of action | Drug/intervention | Experimental model | Outcome | References |
|---|---|---|---|---|---|---|---|
| Cooperating Effect | AURORA | Kinase | Forms complex with Aurora-A kinase to stabilize MYCN | HLB-0532259, PHA-68062 | MNA-NB xenograft mouse | Significant tumor suppression | Tang et al., 2025, Boi et al., 2021 |
| ALK | Receptor tyrosine kinase | Dual inhibitor reduces MYCN expression | ESK44 (Phase I) | NB-1 cells | Inhibits tumor activity | Chugh et al., 2025 | |
| MAX | Transcription factor | MYCN requires dimerization with MAX for oncogenic function | - | Primary NB tissue | Regulates oncogenic activity | Ferrucci et al. (2018) | |
| WDR5 | Chromatin remodeler | Targets WBM/WIN sites to disrupt transcriptional complex | OICR-9429 | MNA-NB cells | Synergistic growth inhibition | Han et al. (2023) | |
| BPTF | Chromatin remodeling factor | Interacts with N-Myc/CRC to regulate cell cycle | - | MNA-NB cells | Potential therapeutic target | Felipe et al. (2024) | |
| IGF2BP1 | RNA-binding protein | Forms cooperative loop with MYCN | BTYNB+YM-155 | MNA-NB cells | Synergistic inhibition | Hagemann et al. (2023) | |
| TCF4 (E2-2) | Transcription factor | Regulates FOXM1/E2F network through super-enhancers | - | Kelly cell line | Controls proliferation | Aljouda et al. (2025) | |
| SMARCE1 | SWI/SNF complex | Regulated by MYCN via non-canonical E-box | - | MNA-NB cells | Inhibits proliferation | Hu et al. (2022) | |
| IRF2BP2 | Transcriptional regulator | Activated by MYCN/MEIS2/HAND2 via SEs | - | MNA-NB cells | Maintains high proliferation | Chen et al. (2024a) | |
| Upstream Regulators | P53 | Tumor suppressor | Indirect MYCN suppression via p53 activation | PRIMA-1, RITA | MNA-NB cells | Delays progression | Mlakar et al. (2019) |
| MDM2 | E3 ubiquitin ligase | Regulates MYCN stability (p53-dependent/independent) | Nutlin-3, MI-63 | TH-MYCN transgenic mice | Delays tumorigenesis | Chen et al. (2009) | |
| PI3K | Signaling kinase | Pathway inhibition reduces MYCN stability | CUDC-907, NVP-BEZ235 | MNA-NB xenograft mouse | Induces degradation | Chanthery et al. (2012) | |
| AF1q | Oncoprotein | Regulates MYCN through Ras/ERK pathways | - | MNA-NB cells | Blocks cell cycle | Oskouian et al. (2024) | |
| Promoter Regulation | CDK7/9/12 | Cyclin-dependent kinases | Inhibits transcriptional elongation of MYCN | THZ1, YKL-5-124 | MNA-NB xenograft mouse | Suppresses tumors | Gao et al. (2021) |
| CRT | Chaperone protein | Binds MYCN promoter to inhibit transcription | Radiation | MNA-NB xenograft mouse | Promotes differentiation | Lee et al. (2019a) | |
| 4-Oct | Transcription factor | Disruption induces caspase-2 apoptosis | - | MNA-NB cells | Reduces oncogenic transcripts | Nakatani et al. (2024) | |
| TFAP4 | Transcription factor | Key effector of MYCN amplification | - | MNA-NB xenograft mouse | Promotes differentiation | Boboila et al. (2018) | |
| AHR | Nuclear receptor | Negatively regulates MYCN promoter | - | MYCN non-amplified cells and MNA-NB cells | Suppresses expression | Wu et al. (2014) | |
| BORIS | DNA-binding protein | Downregulation inhibits MYCN expression | - | MNA-NB xenograft mouse | Induces senescence | Rao et al. (2022) | |
| PP2A | Phosphatase | Dephosphorylates MYCN | ATUX-3364/8385 | MNA-NB cells | Inhibits growth | Nazam et al. (2024) | |
| Downstream (Activated) | GCL (cat) | Metabolic enzyme | MYCN activates via E-box binding (antioxidant pathway) | - | MYCN non-amplified cells and MNA-NB cells | Oxidative stress resistance | Veas-Perez de Tudela et al. (2010) |
| E2F5 | Transcription factor | Direct transcriptional activation by MYCN | - | MNA-NB cells | Promotes cell cycle | Liu et al. (2019) | |
| PHGDH | Metabolic enzyme | MYCN-driven serine metabolism | - | MNA-NB cells | Metabolic reprogramming | Arlt et al. (2021) | |
| MTHFD1 | Metabolic enzyme | MYCN-activated folate metabolism | MTX+JQ1 | MYCN non-amplified cells/MNA-NB cells/MNA-NB xenograft mouse | Therapy sensitization | Guan et al. (2024) | |
| INSM1 | Transcription factor | Direct MYCN target | HHT | MNA-NB cells | Growth inhibition | Chen et al. (2023) | |
| SAGA complex | Epigenetic regulator | MYCN-dependent activity | KAT2A/B PROTAC | MNA-NB cells | Essential for MYCN | Malone et al. (2024) | |
| Downstream (Repressed) | DKK1 | Wnt inhibitor | Suppressed by MYCN | - | MNA-NB cells | Inhibits invasion | Koppen et al. (2007) |
| DKK3 | Wnt modulator | MYCN/miR-92-mediated suppression | Wnt agonists | MNA-NB cells | Promotes malignancy | Chen et al. (2024b) | |
| TFPI2 | Protease inhibitor | Downregulated by MYCN | - | MNA-NB cells | Enhances invasion | Becker et al. (2008) | |
| SESN1 | Stress-response protein | MYCN-regulated | - | MNA-NB cells | Inhibits migration | Hua et al. (2024) | |
| CD9 | Surface glycoprotein | Transcriptional repression by MYCN/HDAC5 | Vorinostat | MYCN non-amplified cells | Suppresses migration | Fabian et al. (2016) | |
| Feedback Loops | INSM1 | Transcription factor | Bidirectional: stabilizes MYCN, activated by MYCN | HHT | MNA-NB cells | Positive feedback | Chen et al., 2015,Chen et al., 2023 |
| PA2G4 | Proliferation protein | Mutual stabilization with MYCN | WS6 analogs | MNA-NB cells | Induces apoptosis | Massudi et al. (2023) | |
| PLK1 | Kinase | Phosphorylates SCF(Fbw7) to stabilize MYCN | - | MNA-NB cells | Enhances oncogenicity | Xiao et al. (2016) | |
| ALDH18A1 | Metabolic enzyme | miR-29b/SP1 regulatory loop | YG1702 | MNA-NB xenograft mouse | Tumor regression | Guo et al. (2020) | |
| SMAD9 | Transcription factor | SE-mediated positive feedback with MYCN | - | MNA-NB cells | Promotes tumorigenesis | Tan et al. (2022) | |
| CRABP-II | Retinol-binding protein | Mutual activation with MYCN | - | MNA-NB cells | Positive feedback | Gupta et al. (2006) | |
| NCYM | Antisense gene | MYCN/OCT4 regulatory loop | ATRA | MNA-NB cells | Expression modulation | Kaneko et al. (2015) |